Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.

Changing the way antibiotics are developed and accessed.

A public-health driven model to tackle AMR.

Our latest news and resources.

Protecting people from the rise and spread of drug-resistant infections.

Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.

Newsletters.

Thumbnail Q32026

Q3 2026: đź’Š Partnership in action: Advancing antibiotic R&D for AMR

View newsletter
Newsletter Q2

Q2 2026: What’s next for antibiotic R&D in a changing global health landscape?

View newsletter
Q1 2026 Newsletter

Q1 2026: Advancing next-generation antibiotics at GARDP

View newsletter
Q4 2025 Newsletter

Q4 2025: Breakthrough in drug-resistant gonorrhoea

View newsletter
Q3 2025 Newsletter

Q3 2025: Partnerships to power antibiotic R&D and access

View newsletter
Q2 2025 Newsletter

Q2 2025: Big wins: Gonorrhoea, sepsis & more!

View newsletter